Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY
|
|
- Lucy Wilkins
- 5 years ago
- Views:
Transcription
1 A Somewhat Different View of the Gene3c Portrait of Chronic Lymphocy3c Leukemia Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY
2 Acknowledgments Davide Bagnara UNIVERSITÀ DEGLI STUDI DI GENOVA Stefano Vergani Andrea Mazzarello Gerardo Ferrer Anthony Liew
3 Tenets In general, the human genome is evolu2onarily designed to correct soma2c muta2ons that might occur Cancer is a disease in which these protec2ve mechanisms ul2mately fail, resul2ng in gene2c derangements of specific, biologically important genes CLL is the same in some ways and different in others. B lymphocytes, the cells that become leukemic in CLL, need to deal with a different evolu2onarily design, i.e., the desired accumula2on of muta2ons in the genes coding for the an2gen-binding regions of an IG molecule by ac2va2oninduced deaminase (AID)
4 IG V-region gene muta3ons in CLL Soma2c muta2ons of IGHV genes divide s/ pa2ents into two categories: U-CLL and M-CLL U-CLL and M-CLL pa2ents differ in their clinical courses IGHV muta2on status remains an important and reliable indicator of clinical course and survival in CLL
5 Almost invariably IGHV muta2on status is fixed. Very rarely does a clone switch from U-CLL to M-CLL, although this can occur However, Sanger sequencing studies indicate that the IGHV-D-J rearrangement of s can undergo intraclonal heterogeneity, even U-CLL cells (Gurrieri et al. 2002; Bagnara et al. 2006; Volkheimer et al. 2007; SuSon et al. 2015) AID, the gene responsible for IGHV-D-J muta2ons, is func2onally ac2ve in CLL. If inten2onally upregulated, this enzyme will mutate CLL V regions, even in U-CLL cells.
6 Ques3ons: How extensive is the ongoing IGHV-D-J muta2on process in CLL? Can this ongoing process be used to predict the likelihood that muta2ons, at least those caused by AID, will occur at sites throughout the genome and thereby possibly lead to clinical progression? Can the IGHV-D-J sequences of the remaining non-cll CD5+ B lymphocytes provide clues to the development of CLL from normal B cells?
7 Approach: Sort all CD5 + cells from CLL pa2ent s blood. This should yield the, its intraclonal variants, and any normal CD5+ B cells ley in the blood Perform high-throughput deep sequencing of the IGHV-D-J repertoire of FACS sorted CD19 + CD5 + from 39 untreated CLL pa2ents Analyze data using appropriate bioinforma2c tools
8 Whole CD5 + B cell repertoire CLL sub-clones Non-leukemic clones
9 Whole CD5+ B cell repertoire CLL sub-clones Non-leukemic clones
10 CLL sub-clones developing through intraclonal diversifica2on can be significantly expanded CLL sub-clones CLL with most expanded sub-clone at > 1% 60% (n = 30) % untreated > 1% < 1% p= TFT (months)
11 s have evolved from precursors differing in IGHV muta2onal load Inferred Germline M- and U-CLL Clinically relevant n=3 n=1 6 only M-CLL
12 Whole CD5 + B cell repertoire CLL sub-clones Non-leukemic clones
13 The CD19 + CD5 + compartment in CLL pa2ents contains leukemic and non-leukemic B-cell clones Whole CD5+ B cell repertoire CLL with non-leukemic VDJ sequences > 0.75% 45% (n = 22) CLL sub-clones 100 > 0.75% < 0.75% Non-leukemic clones % untreated 50 p= TFT (months)
14 Whole CD5 + B cell repertoire CLL sub-clones Non-leukemic clones
15 CD19 + CD5 + B-cell popula2on can present an a second MBL-like clonal expansion Whole CD5+ B cell repertoire CLL with most expanded non- at > 1% 24% (n = 12) most expanded non-leukemic clone cells/ul Absolute fitness Non-leukemic clones high-count MBL 19% (n=6) low-count MBL 42% (n=12) Rela2ve fitness smaller clones not smaller clon not CLL clo
16 Whole CD5+ B cell repertoire CLL sub-clones Non-leukemic clones
17 CD19 + CD5 + non-leukemic B-cell popula2on can be oligoclonally expanded CLL with 3 clones cons2tu2ng > 50% of the non-leukemic sequences 67% (n = 31) Non-leukemic clones
18 CLL present stereotyped IGHV-D-J sequences (Agathangelidis et al. Blood, 2012)
19 CLL-like stereotyped IGHV-D-J sequences can oyen be found among the non-leukemic clones in the CD19 + CD5 + compartment Non-leukemic clones CLL samples (n=50) CLL Leukemic clone 1 1 Non leukemic clones CLL major subsets % of stereotyped clones Sample with stereotyped non-leukemic (n=2) Clones (n=6) 12% Samples with stereotyped (n=6) 12% (Agathangelidis et al. Blood, 2012) (x7), 3, 5, 14 (x2), 64B (x2) Non s Memory Memory IgD Naive Transitional 8 64B 9 1 (x5), 8 (IgG, UM) 10 4 (IgG, M), 64B
20 Implica2ons In > 80% of M-CLL pa2ents, IGHV-D-J sequence with lower muta2on load can be detected The leukemogenic process might start in a cell with less IGHV soma2c muta2ons
21 Implica2ons Non-leukemic CD5 + B cells can display MBL-like oligoclonal expansion and CLL stereotypes - MBL-like oligoclonal origin of CLL - Genomic muta2onal events can occur at two stages of B-cell matura2on: - prior to IGHV-D-J recombina3on: ini2a2ng muta2on. (contribu2on of inherited factors?) - a`er IGHV-D-J recombina3on: final leukemogenic muta2on Do not recapitulate typical CLL VH genes usage and HCDR3 length distribu2on - The final leukemogenic hint involve a further BCR selec2on
22 Implica2ons IGHV-D-J repertoire of CD5 + B cells can be clinically relevant: - Expanded CLL subclones might be a proxy of AID off-target muta2ons ac2vity and thereby indicate the poten2al genera2on of aggressive sub-clonal variants - Abundance of CD5 + non-leukemic sequences directly correlates with bemer outcome
23 Acknowledgments Davide Bagnara UNIVERSITÀ DEGLI STUDI DI GENOVA Stefano Vergani Andrea Mazzarello Gerardo Ferrer Anthony Liew
24
25
26 CD19 + CD5 + non-leukemic B-cell popula2on can be oligoclonally expanded Non-leukemic clones Most expanded clone > 25% of the non-leukemic sequences 65% (n = 30)
27 CD19 + CD5 + non-leukemic B-cell popula2on can be oligoclonally expanded Non-leukemic clones
28 Non-leukemic clones in the CD19 + CD5 + compartment do not present VH genes usage and HCDR3 length distribu2on typical of CLL CLL IgM controls non leukemic CD5+ clones 0.25 Mutated Sequences Un Mutated Sequences CLL Mutated sequences Un Mutated sequences IgM controls 0.20 non leukemic CD5+ clones 0.10 Frequency Frequency IGHV1 69 IGHV3 23 IGHV4 34 IGHV1 69 IGHV3 23 IGHV HCDR3 aa length
NGS IMMUNOGENETICS IN CLL RESEARCH. Andreas Agathangelidis Post-doc researcher Institute of Applied Biosciences, CERTH
NGS IMMUNOGENETICS IN CLL RESEARCH Andreas Agathangelidis Post-doc researcher Institute of Applied Biosciences, CERTH ERIC & Euroclonality-NGS workshop Rotterdam, 24 November 2017 1. NGS Immunoprofiling
More informationB and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14
B and T cell Memory Bengt Lindbom Adap6ve Immunity BMC D14 Immunity: a historical perspec6ve 430 B.C. Thucydides describes the ongoing plague of Athens:.the same man was never attacked twice 15th century:
More informationAML Genomics 11/27/17. Normal neutrophil maturation. Acute Myeloid Leukemia (AML) = block in differentiation. Myelomonocy9c FAB M5
AML Genomics 1 Normal neutrophil maturation Acute Myeloid Leukemia (AML) = block in differentiation AML with minimal differen9a9on FAB M1 Promyelocy9c leukemia FAB M3 Myelomonocy9c FAB M5 2 1 Principle
More informationBiomarkers in Chronic Lymphocytic Leukemia: the art of synthesis. CLL Immunogenetics. Overview. Anastasia Chatzidimitriou
Biomarkers in Chronic Lymphocytic Leukemia: the art of synthesis CLL Immunogenetics Overview Anastasia Chatzidimitriou Belgrade March 17, 2018 B cells: multiple receptors B cell receptor IG unique signature
More informationEvolu&on of Disease genes
Evolu&on of Disease genes Many human diseases are caused by muta1ons in single genes A synthe&c pathway and associated diseases Autosomal dominant condi&ons Dominant Disorders A single mutant gene is sufficient
More informationEvolu+on of Disease genes
Evolu+on of Disease genes Many human diseases are caused by muta1ons in single genes 1 A synthe+c pathway and associated diseases Autosomal dominant condi+ons 2 Dominant Disorders A single mutant gene
More informationChapter 5. Generation of lymphocyte antigen receptors
Chapter 5 Generation of lymphocyte antigen receptors Structural variation in Ig constant regions Isotype: different class of Ig Heavy-chain C regions are encoded in separate genes Initially, only two of
More informationIntraclonal Cell Expansion and Selection Driven by B Cell Receptor in Chronic Lymphocytic Leukemia
Intraclonal Cell Expansion and Selection Driven by B Cell Receptor in Chronic Lymphocytic Leukemia Monica Colombo, 1 Giovanna Cutrona, 1,2 Daniele Reverberi, 1 Sonia Fabris, 3 Antonino Neri, 3 Marina Fabbi,
More informationMBL in Blood Donors: An Extended Immunophenotypic Analysis of CLL-like, CD5+ MBL.
1 th Canadian CLL Meeting Winnipeg, Manitoba Inn at the Forks September 18-19, 214 MBL in Blood Donors: An Extended Immunophenotypic Analysis of CLL-like, CD5+ MBL. Fatima Abbasi 1, Justin Meskas 2, Ryan
More informationImmunological aspects in chronic lymphocytic leukemia (CLL) development
Ann Hematol (2012) 91:981 996 DOI 10.1007/s00277-012-1460-z REVIEW ARTICLE Immunological aspects in chronic lymphocytic leukemia (CLL) development Ricardo García-Muñoz & Verónica Roldan Galiacho & Luis
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationReconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer
Reconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer Darryl Shibata Professor of Pathology University of Southern California Keck School of Medicine dshibata@usc.edu
More informationPrepared by: Dr.Mansour Al-Yazji
C L L CLL Prepared by: Abd El-Hakeem Abd El-Rahman Abu Naser Ahmed Khamis Abu Warda Ahmed Mohammed Abu Ghaben Bassel Ziad Abu Warda Nedal Mostafa El-Nahhal Dr.Mansour Al-Yazji LEUKEMIA Leukemia is a form
More informationImmunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients
Research article Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients Renee C. Tschumper, 1 Susan M. Geyer, 2 Megan E. Campbell, 2 Neil
More informationThe Hierarchical Organization of Normal and Malignant Hematopoiesis
The Hierarchical Organization of Normal and Malignant Hematopoiesis NORMAL Hematopoie2c Stem Cell (HSC) Leukemia Stem Cells (LSC) MPP MLP CMP Leukemic Progenitors MEP GMP B/NK ETP Leukemic Blasts Erythrocytes
More informationReac%ve and Benign Flow Cytometry findings
Reac%ve and Benign Flow Cytometry findings Lymph nodes and other /ssues Sindhu Cherian, MD University of Washington, Sea
More informationThe 1 World Congress on Controversies in Hematology (COHEM) Rome, September 2010
The 1 World Congress on Controversies in Hematology (COHEM) Rome, September 2010 Is the wait and watch philosophy still practical in the treatment of CLL even in younger patients? Expected to say NO Federico
More informationIn developed countries (like the U.S.) we really only have to worry about viruses and bacteria
The immune system dis1nguishes self from non- self When we think of the immune system, we o>en only think that it protects us from pathogens (bacteria, viruses, fungi, parasites) But, the immune system
More informationImportance of minor TP53 mutated clones in the clinic
Importance of minor TP53 mutated clones in the clinic Davide Rossi, M.D., Ph.D. Hematology IOSI - Oncology Institute of Southern Switzerland IOR - Institute of Oncology Reserach Bellinzona - Switzerland
More informationIgCLL group activities in 2009 and beyond. Kostas Stamatopoulos Hematology Department and HCT Unit George Papanicolaou Hospital, Thessaloniki, Greece
IgCLL group activities in 2009 and beyond Kostas Stamatopoulos Hematology Department and HCT Unit George Papanicolaou Hospital, Thessaloniki, Greece Troubleshooting Standardization Standardization and
More informationCharacteriza*on of Soma*c Muta*ons in Cancer Genomes
Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger
More informationGeneration of antibody diversity October 18, Ram Savan
Generation of antibody diversity October 18, 2016 Ram Savan savanram@uw.edu 441 Lecture #10 Slide 1 of 30 Three lectures on antigen receptors Part 1 : Structural features of the BCR and TCR Janeway Chapter
More informationDetection of Burkitt Lymphoma immunoglobulin rearrangements in blood may have prognostic value
Detection of Burkitt Lymphoma immunoglobulin rearrangements in blood may have prognostic value Katharine Lombardo Fred Hutchinson Cancer Research Center 1 Outline B cell receptor in normal cells and in
More informationEpigenetic programming in chronic lymphocytic leukemia
Epigenetic programming in chronic lymphocytic leukemia Christopher Oakes 10 th Canadian CLL Research Meeting September 18-19 th, 2014 Epigenetics and DNA methylation programming in normal and tumor cells:
More informationMissing Heritablility How to Analyze Your Own Genome Fall 2013
Missing Heritablility 02-223 How to Analyze Your Own Genome Fall 2013 Heritability Heritability: the propor>on of observed varia>on in a par>cular trait (as height) that can be agributed to inherited gene>c
More informationCancer Genomics and Personalized Oncology. Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group
Cancer Genomics and Personalized Oncology Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group Cancer in Brazil 600,000 new cases/year Popula0on: 210,867,959 Number of new cases:
More informationIntroduction. Introduction. Lymphocyte development (maturation)
Introduction Abbas Chapter 8: Lymphocyte Development and the Rearrangement and Expression of Antigen Receptor Genes Christina Ciaccio, MD Children s Mercy Hospital January 5, 2009 Lymphocyte development
More informationIntroduc)on to Immunology. T Cell Development
Introduc)on to Immunology T Cell Development Adolfo Ferrando af2196@columbia.edu Thymic stroma cells provide the microenvironment for T cell development. T cells develop from progenitors that are derived
More informationEmerging gene)cs in schizophrenia: Real challenges for crea)ng animal models
Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models Steven A McCarroll, PhD Stanley Center for Psychiatric Research, Broad Ins7tute Department of Gene7cs, Harvard Medical School
More informationAdaptive Immune System
Short Course on Immunology Adaptive Immune System Bhargavi Duvvuri Ph.D IIIrd Year (Immunology) bhargavi@yorku.ca Supervisor Dr.Gillian E Wu Professor, School of Kinesiology and Health Sciences York University,
More informationTumor suppression by modulating stem cell fitness. James DeGregori University of Colorado Denver School of Medicine
Tumor suppression by modulating stem cell fitness James DeGregori University of Colorado Denver School of Medicine Natural Selection can explain cancer incidence at the species level Intrinsic TS Integral
More informationPathology of the indolent B-cell lymphomas Elias Campo
Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell
More informationPaget s Disease of Bone
Paget s Disease of Bone Copyright Copyright 2019 American 2019 American Associa7on Associa7on of Clinical of Clinical Endocrinologists Endocrinologists 1 A Common Bone Disorder Paget s disease of bone
More informationClassifica4on. CSCI1950 Z Computa4onal Methods for Biology Lecture 18. Ben Raphael April 8, hip://cs.brown.edu/courses/csci1950 z/
CSCI1950 Z Computa4onal Methods for Biology Lecture 18 Ben Raphael April 8, 2009 hip://cs.brown.edu/courses/csci1950 z/ Binary classifica,on Given a set of examples (x i, y i ), where y i = + 1, from unknown
More informationB cell activation and antibody production. Abul K. Abbas UCSF
1 B cell activation and antibody production Abul K. Abbas UCSF 2 Lecture outline B cell activation; the role of helper T cells in antibody production Therapeutic targeting of B cells 3 Principles of humoral
More informationAntibodies and T Cell Receptor Genetics Generation of Antigen Receptor Diversity
Antibodies and T Cell Receptor Genetics 2008 Peter Burrows 4-6529 peterb@uab.edu Generation of Antigen Receptor Diversity Survival requires B and T cell receptor diversity to respond to the diversity of
More informationFrom Pathogenesis to Treatment of Chronic Lymphocytic Leukaemia (printer-friendly)
www.medscape.com Authors and Disclosures Thorsten Zenz*, Daniel Mertens*, Ralf Küppers, Hartmut Döhner* & Stephan Stilgenbauer* *Department of Internal Medicine III, University of Ulm, Ulm 89081, Germany.
More informationall of the above the ability to impart long term memory adaptive immunity all of the above bone marrow none of the above
1. (3 points) Immediately after a pathogen enters the body, it faces the cells and soluble proteins of the innate immune system. Which of the following are characteristics of innate immunity? a. inflammation
More informationPhysiology Unit 3 THE SPECIFIC IMMUNE RESPONSE
Physiology Unit 3 THE SPECIFIC IMMUNE RESPONSE The Adap4ve Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired as you are exposed to diseases The immune
More informationIntroduction to Immunology Part 2 September 30, Dan Stetson
Introduction to Immunology Part 2 September 30, 2016 Dan Stetson stetson@uw.edu 441 Lecture #2 Slide 1 of 26 CLASS ANNOUNCEMENT PLEASE NO TREE NUTS IN CLASS!!! (Peanuts, walnuts, almonds, cashews, etc)
More informationSubmitted to Leukemia as a Letter to the Editor, May Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.
Submitted to Leukemia as a Letter to the Editor, May 2007 To the Editor, Leukemia :- Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69. Gender plays an important role in the incidence,
More informationAlessandra Franco, M.D., Ph.D. UCSD School of Medicine Department of Pediatrics Division of Allergy, Immunology and Rheumatology
Natural regulatory T cells recognize the heavy constant region (Fc) of immunoglobulins: a novel mechanism for IVIG immunotherapy in Pediatric Immune-mediated diseases Alessandra Franco, M.D., Ph.D. UCSD
More informationCELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.
!! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)
More informationSession 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi
Session 5 Pre-malignant clonal hematopoietic proliferations Chairs: Frank Kuo and Valentina Nardi Pre-malignant clonal hematopoietic proliferations Clonal LYMPHOID proliferations: - Monoclonal gammopathy
More informationThe Generation of Specific Immunity
The Generation of Specific Immunity Antibody structure! Antibodies classified by specificity (antigen, binding site) and class (general structure, function)! Differences in variable regions produce different
More informationCLL Sample! Clinical Trials! Accrual, tracking,! correlative studies! Immunophenotyping! Surface & intracellular! ZAP-70/CD38! prognosis!
ZAP-70/CD38! prognosis! IGHV! Mutational status! prognosis! Cytogenetics! FISH! karyotype! Cellular Kinetics! B-cell turnover rates! CD38/Ki67/CXCR4! Buccal swabbs! Germline DNA! Genetics studies! Immunophenotyping!
More informationADRL Advanced Diagnostics Research Laboratory
ADRL Advanced Diagnostics Research Laboratory John DeCoteau, MD FRCP Department of Pathology, Division of Hematopathology University of Saskatchewan Saskatchewan Cancer Agency ADRL Project Objectives New
More informationB Lymphocyte Development and Activation
Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai 09/26/05; 9 AM Shiv Pillai B Lymphocyte Development and Activation Recommended
More informationTranslocations and clonality detection in lymphoproliferative disorders by capturebased Next-generation sequencing
Translocations and clonality detection in lymphoproliferative disorders by capturebased Next-generation sequencing Dörte Wren MSc MPhil on behalf of the EuroClonality-NGS consortium Molecular Diagnostics
More informationBiosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016
Biosta's'cs Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Review key biosta's'cs concepts Understand 2 X 2 tables Objec'ves By the end of this
More informationDevelopment of B and T lymphocytes
Development of B and T lymphocytes What will we discuss today? B-cell development T-cell development B- cell development overview Stem cell In periphery Pro-B cell Pre-B cell Immature B cell Mature B cell
More informationChapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally!
MCMP422 Immunology and Biologics Immunology is important personally and professionally! Learn the language - use the glossary and index RNR - Reading, Note taking, Reviewing All materials in Chapters 1-3
More informationUNCONSCIOUS BIAS What is it? Sponsored by InDemand Interpre1ng
1 UNCONSCIOUS BIAS What is it? 2 Unconscious Bias: What is it? How does it work? By: David B. Hunt, J.D. President and CEO, Cri8cal Measures Awareness: New Research Regarding Bias 3 In the past, bias was
More informationEpigene.cs: What is it and how it effects our health? Overview. Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa
Epigene.cs: What is it and how it effects our health? Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa Overview Basic Background Epigene.cs in general Epigene.cs in cancer Epigene.cs
More informationDiscordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial
Discordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial Dean Follmann, Erica BriDain, and John Powers Na5onal Ins5tute of Allergy and Infec5ous Diseases November 19, 2014 1 Current
More informationJPEMS 2014 Basic Immunology module Activation and functions of T lymphocytes
JPEMS 2014 Basic Immunology module Activation and functions of T lymphocytes Teacher: Pr. Régis Josien, Laboratoire d Immunologie, CHU Nantes Regis.Josien@univ-nantes.fr 1 An#gen recogni#on by T cells
More informationMolecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU
Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationPart 2: Cancer Therapies, Present and Future. Adrianna San Roman Leah Liu Clare Malone
Part 2: Cancer Therapies, Present and Future Adrianna San Roman Leah Liu Clare Malone Objec?ves Most cancer therapies aback general features common to all cancers New cancer therapies aback specific features
More informationNew Fron)ers in Therapies for Autoimmunity
New Fron)ers in Therapies for Autoimmunity Preview Discuss spectrum of autoimmune research at MUSC Iden)fy some of the key inves)gators in basic and clinical research at MUSC Discuss specific areas of
More informationDevelopment and Behavioral Gene2cs. PSC 113 Jeff Schank
Development and Behavioral Gene2cs PSC 113 Jeff Schank Outline Unifactorial Methods Vasopressin Deficiency Mul2 factorial Methods (Quan2ta2ve Gene2cs) Heritability The IQ Controversy What are Intelligent
More informationInherited breast and ovarian cancer
Inherited breast and ovarian cancer Pr François Duhoux Medical Oncology and Center for Human Genetics Breast Incidence - Mortality.be: 147.5 29.5 Life9me risk : 12% IARC EUCAN Fact Sheets 2 1 Breast cancer
More informationARTICLE RESEARCH. Macmillan Publishers Limited. All rights reserved
Extended Data Figure 6 Annotation of drivers based on clinical characteristics and co-occurrence patterns. a, Putative drivers affecting greater than 10 patients were assessed for enrichment in IGHV mutated
More informationProcess of Science and hypothesis tes2ng in Behavioral Ecology
Process of Science and hypothesis tes2ng in Behavioral Ecology Goal: understand the way that scien2fic hypotheses and methodologies are used to gain knowledge. What separates science from non- science?
More informationAntigen-Independent B-Cell Development Bone Marrow
Antigen-Independent B-Cell Development Bone Marrow 1. DNA rearrangements establish the primary repertoire, creating diversity 2. Allelic exclusion ensures that each clone expresses a single antibody on
More informationThe Adaptive Immune Response. B-cells
The Adaptive Immune Response B-cells The innate immune system provides immediate protection. The adaptive response takes time to develop and is antigen specific. Activation of B and T lymphocytes Naive
More informationRichter syndrome: pathogenesis and management. Clemens Wendtner Professor of Medicine Chief Physician Klinikum Schwabing University of Munich
Richter syndrome: pathogenesis and management Clemens Wendtner Professor of Medicine Chief Physician Klinikum Schwabing University of Munich Conflict of Interest Disclosure I hereby declare the following
More informationGene+c fate mapping. x loxp. Foxp3 3 UTR ROSA26 RFP IRES GFP CRE. STOP loxp. Stable Foxp3 expression. Foxp3 expression in new Treg.
1 Introduc+on (CD4 + CD25 + Foxp3 + )are indispensable for immune homeostasis. Muta+ons in Foxp3 gene leads to fatal autoimmune disorder. Condi+onal dele+on of Foxp3 reprograms cells into pathogenic Th
More informationThe Importance of Iden0fying Women at Risk for BRCA1/2 Muta0ons for Referral to Cancer Gene0cs Services
The Importance of Iden0fying Women at Risk for BRCA1/2 Muta0ons for Referral to Cancer Gene0cs Services Cecelia Bellcross, PhD, MS, CGC Emory University School of Medicine Department of Human Gene0cs Alliance
More informationResearch Strategy: 1. Background and Significance
Research Strategy: 1. Background and Significance 1.1. Heterogeneity is a common feature of cancer. A better understanding of this heterogeneity may present therapeutic opportunities: Intratumor heterogeneity
More informationκ λ Antigen-Independent B-Cell Development Bone Marrow Ordered Rearrangement of Ig Genes During B-Cell Development in the Bone Marrow
Antigen-Independent B-Cell Development Bone Marrow 1. DNA rearrangements establish the primary repertoire, creating diversity 2. Allelic exclusion ensures that each clone expresses a single antibody on
More informationChapter 11. B cell generation, Activation, and Differentiation. Pro-B cells. - B cells mature in the bone marrow.
Chapter B cell generation, Activation, and Differentiation - B cells mature in the bone marrow. - B cells proceed through a number of distinct maturational stages: ) Pro-B cell ) Pre-B cell ) Immature
More informationIncidental Absolute Leukocytosis Connie Shen, MS2
Incidental Absolute Leukocytosis Connie Shen, MS2 Clinical History An otherwise healthy 73-year-old Caucasian man presents for a rou=ne physical. Review of systems is nega=ve. A CBC was obtained and reveals
More informationPhenotypes of Dyslipidemia A mechanis8c approach to management. Disclosures. Consultant FGH Research Funding Synageva, Inc.
Phenotypes of Dyslipidemia A mechanis8c approach to management John P. Kane, M.D., Ph.D. Professor of Medicine University of alifornia, San Francisco Disclosures onsultant FGH Research Funding Synageva,
More informationMolecular mechanisms in atopic eczema - why do they ma6er in the clinic?
Molecular mechanisms in atopic eczema - why do they ma6er in the clinic? Sara Brown Professor of Molecular & Gene0c Dermatology Wellcome Trust Senior Fellow in Clinical Research Professor of Molecular
More informationInference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 C.J.Vaske et al. May 22, 2013 Presented by: Rami Eitan Complex Genomic
More informationGenetic Tests and Genetic Counseling How to Analyze Your Own Genome
Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and
More informationChronic lymphocytic leukemia is eradication feasible and worthwhile?
Chronic lymphocytic leukemia is eradication feasible and worthwhile? Gianluca Gaidano, MD, PhD Division of Hematology Department of Clinical and Experimental Medicine Amedeo Avogardo University of Eastern
More informationThird line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!
Topic 8 Specific Immunity (adaptive) (18) Topics - 3 rd Line of Defense - B cells - T cells - Specific Immunities 1 3 rd Line = Prophylaxis via Immunization! (a) A painting of Edward Jenner depicts a cow
More informationShort Telomeres Predict Poor Prognosis in Chronic Lymphocytic Leukemia
Short Telomeres Predict Poor Prognosis in Chronic Lymphocytic Leukemia L. Yang Internal Medicine Resident University of Manitoba Supervisor: Dr. J. Johnston Prognostic factors Clinical course is unpredictable
More informationThe Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.
The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development
More informationTemplate for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version: CLLBiomarkers 1.0.0.2 Protocol Posting Date: June 2017
More informationTranscript-indexed ATAC-seq for immune profiling
Transcript-indexed ATAC-seq for immune profiling Technical Journal Club 22 nd of May 2018 Christina Müller Nature Methods, Vol.10 No.12, 2013 Nature Biotechnology, Vol.32 No.7, 2014 Nature Medicine, Vol.24,
More informationWilson Disease Watch July-September vol 5
Wilson Disease Watch July-September 2012. vol 5 - Latest ar)cles : Summary and comments - Long Term Follow Up - SSIEM Congress 2012 - Agenda EuroWilsoN: European Wilson s Disease Network Improving informa)on,
More informationIg light chain rearrangement: Rescue pathway
B Cell Development Ig light chain rearrangement: Rescue pathway There is only a 1:3 chance of the join between the V and J region being in frame Vk Jk Ck Non-productive Rearrangement Light chain has a
More informationChapter 11. B cell generation, Activation, and Differentiation. Pro-B cells. - B cells mature in the bone marrow.
Chapter B cell generation, Activation, and Differentiation - B cells mature in the bone marrow. - B cells proceed through a number of distinct maturational stages: ) Pro-B cell ) Pre-B cell ) Immature
More informationSPECIFIC IMMUNITY = ACQUIRED IMMUNITY = ADAPTIVE IMMUNITY SPECIFIC IMMUNITY - BASIC CHARACTERISTIC
SPECIFIC IMMUNITY - BASIC CHARACTERISTIC SPECIFIC IMMUNITY = ACQUIRED IMMUNITY = ADAPTIVE IMMUNITY BASIC TERMINOLOGY SPECIFIC IMMUNITY humoral mediated with antibodies cellular mediated with T lymphocytes
More informationPATRICK ANSAH PRINCIPAL INVESTIGATOR 22/02/2016
Evaluation of the Men A specific antibody persistence in Ghanaian children more than five years after immunization with PsA-TT (2.5 μg, 5 μg, or 10 μg polysaccharide concentration) PATRICK ANSAH PRINCIPAL
More informationIntroduction. Abbas Chapter 10: B Cell Activation and Antibody Production. General Features. General Features. General Features
Introduction Abbas Chapter 10: B Cell Activation and Antibody Production January 25, 2010 Children s Mercy Hospitals and Clinics Humoral immunity is mediated by secreted antibodies (Ab) Ab function to
More informationChapter 26. Newborn Screening
Chapter 26 Newborn Screening Severe Combined Immune Deficiency (SCID) leads to life-threatening infections unless the immune system can be restored through a bone marrow transplant, enzyme replacement
More informationImmunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1360 Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia Characterization of New Prognostic and Biological Subsets
More informationHuman B Cell Responses to Influenza Virus Vaccination
Human B Cell Responses to Influenza Virus Vaccination Nucleoprotein (RNA) Influenza Virus Neuraminidase (NA) Hemagglutinin (HA) Enveloped, single-stranded, negative-sense RNA virus with segmented genome.
More informationCopy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015
Copy Number Varia/on Detec/on Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Today s Goals Understand the applica5on and capabili5es of using targe5ng sequencing and CNV calling
More informationChronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo
Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas NAIVE -B LYMPHOCYTE MEMORY CELL CLL MCL FL MZL Small cell size Low proliferation
More informationXIII. Molecular pathogenesis of transformed lymphomas
Hematological Oncology Hematol Oncol 2015; 33: 70 74 Published online in Wiley Online Library (wileyonlinelibrary.com).2221 Supplement Article XIII. Molecular pathogenesis of transformed lymphomas Davide
More informationEvolu)on of drug resistance. The evolu)on of drug resistance. 1. Forms of resistance: Resistance to drugs. 1. Forms of resistance: Resistance to drugs
The evolu)on of drug resistance Drug resistance describes the ability of a parasite or pathogen to overcome our a9empts to control them. Drug resistance has evolved to become a worldwide health threat.
More informationB-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow
B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow Sanam Loghavi, MD Department of Hematopathology University of Texas MD Anderson Cancer Center Houston, TX Disclosures I have no
More informationQuan%ta%ve Tools for Benefit/Risk Op%miza%on in Medical Imaging MIRD CommiAee Pamphlet
Quan%ta%ve Tools for Benefit/Risk Op%miza%on in Medical Imaging MIRD CommiAee Pamphlet Wesley Bolch, PhD, PE, DABHP, FHPS, FAAPM Medical Physics Program Department of Biomedical Engineering University
More informationClinical Staging and the At-Risk Phase of Psychotic Disorder
Clinical Staging and the At-Risk Phase of Psychotic Disorder Sabina Abidi MD FRCPC IWK Youth Psychosis Program Capital Health Nova ScoCa Early Psychosis Program Key Findings in Early Psychosis Knowledge
More informationNeuroendocrine Prostate Cancer (NEPC)
Neuroendocrine Prostate Cancer (NEPC) Jehonathan H. Pinthus MD, Ph.D. Associate professor Department of Surgery- Urology McMaster University The 27th Annual Interna/onal Prostate Cancer Update (IPCU 27)
More information